A detailed history of Rhumbline Advisers transactions in Haleon PLC stock. As of the latest transaction made, Rhumbline Advisers holds 52,996 shares of HLN stock, worth $497,632. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,996
Previous 48,966 8.23%
Holding current value
$497,632
Previous $404,000 38.61%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$8.32 - $10.7 $33,529 - $43,121
4,030 Added 8.23%
52,996 $560,000
Q2 2024

Aug 01, 2024

BUY
$8.01 - $8.64 $65,361 - $70,502
8,160 Added 20.0%
48,966 $404,000
Q1 2024

May 09, 2024

BUY
$8.02 - $8.67 $85,116 - $92,014
10,613 Added 35.15%
40,806 $346,000
Q4 2023

Feb 08, 2024

BUY
$7.78 - $8.62 $10,176 - $11,274
1,308 Added 4.53%
30,193 $248,000
Q3 2023

Nov 09, 2023

BUY
$7.85 - $8.94 $59,738 - $68,033
7,610 Added 35.77%
28,885 $240,000
Q2 2023

Aug 08, 2023

BUY
$8.04 - $9.0 $171,050 - $191,475
21,275 New
21,275 $178,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.